Efficacy and safety of FiLaC™ for perianal fistulizing Crohn’s disease: a systematic review and meta-analysis

被引:0
|
作者
D. Cao
W. Li
Y. Ji
X. Wang
Z. Cui
机构
[1] Shanghai Jiao Tong University,Department of Gastrointestinal Surgery, Ren Ji Hospital, School of Medicine
[2] Shanghai Jiao Tong University,School of Medicine
[3] Shanghai Jiao Tong University,Baoshan Branch, Ren Ji Hospital, School of Medicine
来源
关键词
Perianal fistulizing Crohn’s disease; FiLaC™; Healing rate; Fecal incontinence; Meta-analysis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:775 / 781
页数:6
相关论文
共 50 条
  • [21] Systematic review with meta-analysis: faecal diversion for management of perianal Crohn's disease
    Singh, S.
    Ding, N. S.
    Mathis, K. L.
    Dulai, P. S.
    Farrell, A. M.
    Pemberton, J. H.
    Hart, A. L.
    Sandborn, W. J.
    Loftus, E. V., Jr.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 42 (07) : 783 - 792
  • [22] Efficacy and safety of adalimumab in pediatric patients with Crohn’s disease: A systematic review and meta-analysis
    Bin Chen
    Zhuan Zou
    Xiaoyan Zhang
    Dongqiong Xiao
    Xihong Li
    European Journal of Clinical Pharmacology, 2024, 80 : 395 - 407
  • [23] Efficacy and safety of adalimumab in pediatric patients with Crohn's disease: A systematic review and meta-analysis
    Chen, Bin
    Zou, Zhuan
    Zhang, Xiaoyan
    Xiao, Dongqiong
    Li, Xihong
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 80 (03) : 395 - 407
  • [24] Efficacy and safety of adalimumab in comparison to infliximab for Crohn's disease: A systematic review and meta-analysis
    Yang, Hua-Hua
    Huang, Yi
    Zhou, Xu-Chun
    Wang, Ruo-Nan
    WORLD JOURNAL OF CLINICAL CASES, 2022, 10 (18) : 6091 - 6104
  • [25] Efficacy and safety of adalimumab in comparison to infliximab for Crohn's disease: A systematic review and meta-analysis
    Hua-Hua Yang
    Yi Huang
    Xu-Chun Zhou
    Ruo-Nan Wang
    World Journal of Clinical Cases, 2022, (18) : 6091 - 6104
  • [26] Systematic review with meta-analysis: the efficacy and safety of stem cell therapy for Crohn's disease
    Qiu, Yun
    Li, Man-ying
    Feng, Ting
    Feng, Rui
    Mao, Ren
    Chen, Bai-li
    He, Yao
    Zeng, Zhi-rong
    Zhang, Sheng-hong
    Chen, Min-hu
    STEM CELL RESEARCH & THERAPY, 2017, 8
  • [27] Efficacy and Safety of Natalizumab and Vedolizumab for the Management of Crohn's Disease: A Systematic Review and Meta-analysis
    Chandar, Apoorva K.
    Singh, Siddharth
    Murad, Mohammad Hassan
    Peyrin-Biroulet, Laurent
    Loftus, Edward V., Jr.
    INFLAMMATORY BOWEL DISEASES, 2015, 21 (07) : 1695 - 1708
  • [28] Systematic review with meta-analysis: the efficacy and safety of stem cell therapy for Crohn’s disease
    Yun Qiu
    Man-ying Li
    Ting Feng
    Rui Feng
    Ren Mao
    Bai-li Chen
    Yao He
    Zhi-rong Zeng
    Sheng-hong Zhang
    Min-hu Chen
    Stem Cell Research & Therapy, 8
  • [29] Efficacy and Safety of Infliximab in Pediatric Crohn Disease: A Systematic Review and Meta-Analysis
    Li, Sophia
    Reynaert, Christopher
    Su, Annie Ling
    Sawh, Sonja
    CANADIAN JOURNAL OF HOSPITAL PHARMACY, 2019, 72 (03): : 227 - 238
  • [30] Comments on "Mesenchymal Stem Cells versus Placebo for Perianal Fistulizing Crohn's Disease: A Systemic Review and Meta-Analysis"
    Cheng, Fang
    SURGICAL INNOVATION, 2023, 30 (06) : 782 - 782